Prechel M M, Lozano Y, Wright M A, Ihm J, Young M R
Research Service, Hines VA Hospital, IL 60141, USA.
Cancer Lett. 1995 Jun 8;92(2):235-42. doi: 10.1016/0304-3835(95)03804-6.
Lewis lung carcinoma (LLC-LN7) tumors stimulate myelopoiesis and induce immunosuppressive granulocyte-macrophage (GM)-progenitor cells. Treating mice having palpable tumors with IL-12 enhanced the frequency of GM-progenitors and did not diminish GM-suppressor activity. Proliferation of splenic T-cells of tumor-bearers to Con-A or to anti-CD3 plus IL-2 was suppressed; this was not enhanced by IL-12 treatment. Also not stimulated was T-cell secretion of IL-2 in response to autologous tumor, or the intratumoral T-cell content. IL-12 slightly increased splenic IFN-gamma secretion, and increased cytotoxicity of lymph node (but not spleen) cells toward autologous tumor. In these tumor-bearing mice that were immune depressed as a result of GM-suppressor cells, immune modulatory effects of IL-12 were marginal and did not affect tumor size or metastasis.
刘易斯肺癌(LLC-LN7)肿瘤刺激骨髓生成并诱导免疫抑制性粒细胞-巨噬细胞(GM)祖细胞。用白细胞介素-12(IL-12)治疗有可触及肿瘤的小鼠,可提高GM祖细胞的频率,且不会降低GM抑制活性。荷瘤小鼠脾T细胞对刀豆蛋白A(Con-A)或抗CD3加IL-2的增殖受到抑制;IL-12治疗并未增强这种抑制作用。对自体肿瘤的反应中,T细胞分泌IL-2以及肿瘤内T细胞含量也未受到刺激。IL-12略微增加了脾脏干扰素-γ(IFN-γ)的分泌,并增强了淋巴结(而非脾脏)细胞对自体肿瘤的细胞毒性。在这些因GM抑制细胞而免疫抑制的荷瘤小鼠中,IL-12的免疫调节作用微弱,且不影响肿瘤大小或转移。